Gender effect on metformin and sitagliptin [Regulatives / Guidelines]

posted by khageswara Rao – India, 2022-03-01 07:26 (76 d 11:56 ago) – Posting: # 22816
Views: 485

Dear All,

As per updated guidelines

If a drug product is intended for use in both sexes, the applicant should include similar proportions of males and females in the study or provide a justification supporting the use of a single-sex population.

for metformin and Sitagliptin we have enrolled only male subjects so please provide the justification on the same of gender effect. with references.

Your quick response will much helpful

Thanks in advance.

Complete thread:

UA Flag
 Admin contact
22,074 posts in 4,629 threads, 1,565 registered users;
online 15 (0 registered, 15 guests [including 14 identified bots]).
Forum time: Monday 20:23 CEST (Europe/Vienna)

Rules are for the guidance of wise men
and the blind obedience of fools.    attributed to Solon

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz